Abstract
Summary
In 87 patients with hereditary hemochromatosis, osteoporosis was detected in 25%, and osteopenia in 41%. Bone mineral density was independently associated with BMI, ALP levels, hypogonadism/menopause, and the amount of iron removed to reach depletion, but not with cirrhosis. Osteoporosis is influenced by iron overload in hemochromatosis.
Introduction
To analyze prevalence, clinical characteristics and genetic background associated with osteoporosis in a retrospective study in Italian patients with hereditary hemochromatosis (HHC).
Methods
In 87 consecutive patients with HHC, bone mineral density was systematically evaluated by dual energy x-ray absorptiometry of the lumbar spine (n = 87) and femoral neck (n = 66).
Results
Osteoporosis was detected in 22 (25.3%), and osteopenia in 36 (41.4%) patients. Mean Z scores were −0.92 ± 1.42 at lumbar spine and −0.35 ± 1.41 at femoral neck. Lumbar spine T-score was independently associated with total ALP (p = 0.002), hypogonadism/menopause (p = 0.026), and iron overload (p = 0.033 for ferritin and p = 0.017 for iron removed). We observed a borderline significance for BMI (p = 0.069) and smoking status (p = 0.086). Lumbar spine osteoporosis was independently associated with lower BMI (OR 0.73, 95% CI 0.54–0.94), total ALP (OR 1.17, 95% CI 1–1.39 per 10 unit increase) and the amount of iron removed (OR 1.53, 95% CI 1–2.5 per 5 g increase). HFE genotypes did not differ between patients with and without osteoporosis.
Conclusions
Osteoporosis is observed in a quarter of unselected patients with HHC, independently of the genetic background, and is associated with ALP, hypogonadism, body weight, and severity of iron overload.
Similar content being viewed by others
References
Pietrangelo A (2004) Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 350:2383–2397
Feder JN, Gnirke A, Thomas W et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408
Camaschella C (2005) Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 106:3710–3717
Valenti L, Pulixi EA, Arosio P et al (2007) Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 92:1037–1042
Nagashima M, Kudo M, Chung H et al (2006) Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatol Res 36:288–293
Harrison-Findik DD, Klein E, Crist C et al (2007) Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology 46:1979–1985
Sinigaglia L, Fargion S, Fracanzani AL et al (1997) Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 24:1809–1813
Guggenbuhl P, Deugnier Y, Boisdet JF et al (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 16:1809–1814
Conte D, Caraceni MP, Duriez J et al (1989) Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 84:1231–1234
Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 110:430–436
Diamond T, Pojer R, Stiel D et al (1991) Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease. Calcif Tissue Int 48:373–379
de Vernejoul MC, Pointillart A, Golenzer CC et al (1984) Effects of iron overload on bone remodeling in pigs. Am J Pathol 116:377–384
Diamond T, Stiel D, Posen S (1991) Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res 6:39–43
Angelopoulos NG, Goula AK, Papanikolaou G et al (2006) Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature. Osteoporos Int 17:150–155
Valenti L, Fracanzani AL, Rossi V et al (2008) The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload. J Rheumatol 35:153–158
Guillygomarc’h A, Mendler MH, Moirand R et al (2001) Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 35:344–349
Scheuer PG, Williams R, Muir AR (1962) Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 84:1–85
Barry M, Sherlock S (1971) Measurement of liver iron concentration in needle biopsy specimens. Lancet 1:100–103
Sampietro M, Piperno A, Lupica L et al (1998) High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 27:181–184
Adams PC, Reboussin DM, Barton JC et al (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769–1778
McDermott JH, Walsh CH (2005) Hypogonadism in hereditary hemochromatosis. J Clin Endocrinol Metab 90:2451–2455
Cundy T, Bomford A, Butler J et al (1989) Hypogonadism and sexual dysfunction in hemochromatosis: the effects of cirrhosis and diabetes. J Clin Endocrinol Metab 69:110–116
Group WHOs (1994) Osteoporosis. In: (eds)(1994) Assesment of fracture risk and its application to screening for post-menopausal osteoporosis. WHO technical report series 843. WHO, Geneva pp
Pedrazzoni M, Girasole G, Bertoldo F et al (2003) Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos Int 14:978–982
Varenna M, Binelli L, Zucchi F et al (1997) Is the metatarsal fracture in postmenopausal women an osteoporotic fracture? A cross-sectional study on 113 cases. Osteoporos Int 7:558–563
Mandelli C, Cesarini L, Piperno A et al (1992) Saturability of hepatic iron deposits in genetic hemochromatosis. Hepatology 16:956–959
Cundy T, Butler J, Bomford A et al (1993) Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis. Clin Endocrinol (Oxf) 38:617–620
Szulc P, Montella A, Delmas PD (2007) High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over - prospective MINOS study. Ann Rheum Dis
Pratelli L, Verri E, Fortini M et al (2006) Chelation therapy and bone metabolism markers in thalassemia major. J Pediatr Endocrinol Metab 19:1335–1342
Salama OS, Al-Tonbary YA, Shahin RA et al (2006) Unbalanced bone turnover in children with beta-thalassemia. Hematology 11:197–202
Acknowledgements and Funding
This paper was supported by COFIN 2004, FIRST 2004, FIRST 2005, Ricerca Corrente Ospedale Maggiore Policlinico Mangiagalli Regina Elena IRCCS 2004, 2005, 2006. Centro Universitario per lo Studio e la Cura delle Malattie Metaboliche del Fegato.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Valenti, L., Varenna, M., Fracanzani, A.L. et al. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int 20, 549–555 (2009). https://doi.org/10.1007/s00198-008-0701-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-008-0701-4